Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Growth Retardation and Adult Height in Children with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Haruko Shima, Chikako Tono, Akihiko Tanizawa, Masaki Ito, Akihiro Watanabe, Yuki Yuza, Kazuko Hamamoto, Hideki Muramatsu, Masahiko Okada, Shoji Saito, Hiroaki Goto, Masaru Imamura, Akiko M Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada

Blood (2024) 144 (Supplement 1): 4537.

https://doi.org/10.1182/blood-2024-198938

Published: 2024

Journal Articles

RARB Translocations in Acute Promyelocytic Leukemia without Rara translocation

Blood (2017) 130 (Supplement 1): 104.

https://doi.org/10.1182/blood.V130.Suppl_1.104.104

Published: 2017

Journal Articles

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes

Blood (2013) 121 (6): 877–883.

https://doi.org/10.1182/blood-2012-06-432500

Published: 2013

Journal Articles

Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia

Yoshiyuki Takahashi, Hideki Muramatsu, Naoki Sakata, Nobuyuki Hyakuna, Kazuko Hamamoto, Ryoji Kobayashi, Etsuro Ito, Hiroshi Yagasaki, Akira Ohara, Akira Kikuchi, Akira Morimoto, Hiromasa Yabe, Kazuko Kudo, Ken-ichiro Watanabe, Shouichi Ohga, Seiji Kojima

Blood (2013) 121 (5): 862–863.

https://doi.org/10.1182/blood-2012-11-465633

Published: 2013

Journal Articles

Heterogeneity in Infants with Acute Myeloid Leukemia: Retrospective Analysis of a Japanese Nationwide Survey

Akira Shimada, MD, PhD, Daisuke Tomizawa, MD, Akitoshi Kinoshita, MD, PhD, Kazuko Hamamoto, MD., PhD, Ichiro Tsukimoto, MD., PhD, Atsushi Ogawa, MD, Takashi Taga, MD, PhD, Toshihiko Imamura, MD, PhD, Akio Tawa, MD, PhD, Keizo Horibe, MD, PhD, Tomohiko Taki, MD, PhD, Yasuhide Hayashi, MD, PhD, Souichi Adachi, MD, PhD

Blood (2011) 118 (21): 1477.

https://doi.org/10.1182/blood.V118.21.1477.1477

Published: 2011

Journal Articles

Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia

Haruko Shima, MD, PhD, Mika Tokuyama, Akihiko Tanizawa, Chikako Tono, Kazuko Hamamoto, Hideki Muramatsu, Akihiro Watanabe, Noriko Hotta, Masaki Ito, Hidemitsu Kurosawa, MD, Koji Kato, MD, PhD, Masahito Tsurusawa, MD, Keizo Horibe, MD, PhD, Hiroyuki Shimada

Blood (2010) 116 (21): 2277.

https://doi.org/10.1182/blood.V116.21.2277.2277

Published: 2010

Journal Articles

Minimal Risidual Disease monitoring in Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Preliminary Results of JPLSG Ph+ALL04.

Hirohide Kawasaki, MD, PhD, Souichi Adachi, MD, PhD, Akira Ohara, MD, Atsushi Kikuta, MD, Atsushi Sato, MD, Hiroyuki Takahashi, MD, Motoaki Chin, MD, Masahiro Tsuchida, MD, Kazuko Hamamoto, MD, Kouichi Matsumoto, MD, Keiko Yagi, MD, Hiromasa Yabe, MD, Makoto Yoshida, MD, Tsutomu Watanabe, MD, Atsushi Manabe, MD, PhD

Blood (2009) 114 (22): 4116.

https://doi.org/10.1182/blood.V114.22.4116.4116

Published: 2009

Journal Articles

Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.

Kazuko Kudo, Seiji Kojima, Ken Tabuchi, Eisaburo Ishii, Hiromasa Yabe, Akio Tawa, Masue Imaizumi, Ryoji Hanada, Kazuko Hamamoto, Ryoji Kobayashi, Akira Morimoto, Hideki Nakayama, Shigeru Tsuchiya, Masahiro Tsuchida, Keizo Horibe, Ichiro Tsukimoto

Blood (2005) 106 (11): 276.

https://doi.org/10.1182/blood.V106.11.276.276

Published: 2005

Journal Articles

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Ichiro Tsukimoto, MD, Akio Tawa, MD, Ryoji Hanada, MD, Ken Tabuchi, MD, Hisato Kigasawa, MD, Shigeru Tsuchiya, MD, Masahiro Tsuchida, MD, Hiromasa Yabe, MD, Hideki Nakayama, MD, Kazuko Kudo, MD, Ryoji Kobayashi, MD, Kazuko Hamamoto, MD, Masue Imaizumi, MD, Akira Morimoto, MD, Keizo Horibe, MD

Blood (2005) 106 (11): 889.

https://doi.org/10.1182/blood.V106.11.889.889

Published: 2005

Journal Articles

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

Masue Imaizumi, MD, Akio Tawa, MD, Ryoji Hanada, MD, Masahiro Tsuchida, MD, Ken Taguchi, MD, Ryoji Kobayashi, MD, Akira Morimoto, MD, Hideki Nakayama, MD, Kazuko Hamamoto, MD, Kazuko Kudo, MD, Hiromasa Yabe, MD, Hisato Kigasawa, MD, Keizo Horibe, MD, Shigeru Tsuchiya, MD, Ichiro Tsukimoto, MD

Blood (2005) 106 (11): 891.

https://doi.org/10.1182/blood.V106.11.891.891

Published: 2005

NARROW

Growth Retardation and Adult Height in Children with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

RARB Translocations in Acute Promyelocytic Leukemia without Rara translocation

Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes

Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia

Heterogeneity in Infants with Acute Myeloid Leukemia: Retrospective Analysis of a Japanese Nationwide Survey

Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia

Minimal Risidual Disease monitoring in Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Preliminary Results of JPLSG Ph+ALL04.

Results of the Japanese Childhood Acute Myeloid Leukemia 99 Protocol for Down Syndrome and Acute Myeloid Leukemia.

Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

Improved Outcome of Combination Therapy with ATRA, Anthracyclines and Cytarabine, AML99-M3 Protocol, for Childhood Acute Promyelocytic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only